Global Adipose Tissue-derived Stem Cell Therapy Market Size, Status And Forecast 2021-2027

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Autologous Stem Cells
1.2.3 Allogeneic Stem Cells
1.3 Market by Application
1.3.1 Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Therapeutic Application
1.3.3 Research Application
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Perspective (2016-2027)
2.2 Adipose Tissue-derived Stem Cell Therapy Growth Trends by Regions
2.2.1 Adipose Tissue-derived Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adipose Tissue-derived Stem Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Adipose Tissue-derived Stem Cell Therapy Industry Dynamic
2.3.1 Adipose Tissue-derived Stem Cell Therapy Market Trends
2.3.2 Adipose Tissue-derived Stem Cell Therapy Market Drivers
2.3.3 Adipose Tissue-derived Stem Cell Therapy Market Challenges
2.3.4 Adipose Tissue-derived Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue
3.1.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adipose Tissue-derived Stem Cell Therapy Revenue
3.4 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adipose Tissue-derived Stem Cell Therapy Revenue in 2020
3.5 Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adipose Tissue-derived Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Adipose Tissue-derived Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adipose Tissue-derived Stem Cell Therapy Breakdown Data by Type
4.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Adipose Tissue-derived Stem Cell Therapy Breakdown Data by Application
5.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size (2016-2027)
6.2 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type
6.2.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2027)
6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application
6.3.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2027)
6.4 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country
6.4.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size (2016-2027)
7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type
7.2.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application
7.3.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country
7.4.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size (2016-2027)
9.2 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Type
9.2.1 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Application
9.3.1 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country
9.4.1 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AlloCure
11.1.1 AlloCure Company Details
11.1.2 AlloCure Business Overview
11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Introduction
11.1.4 AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.1.5 AlloCure Recent Development
11.2 Antria
11.2.1 Antria Company Details
11.2.2 Antria Business Overview
11.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Introduction
11.2.4 Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.2.5 Antria Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
11.3.4 Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.3.5 Celgene Corporation Recent Development
11.4 Cellleris
11.4.1 Cellleris Company Details
11.4.2 Cellleris Business Overview
11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Introduction
11.4.4 Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.4.5 Cellleris Recent Development
11.5 Corestem
11.5.1 Corestem Company Details
11.5.2 Corestem Business Overview
11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Introduction
11.5.4 Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.5.5 Corestem Recent Development
11.6 Cytori Therapeutics
11.6.1 Cytori Therapeutics Company Details
11.6.2 Cytori Therapeutics Business Overview
11.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.6.4 Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.6.5 Cytori Therapeutics Recent Development
11.7 Intrexon
11.7.1 Intrexon Company Details
11.7.2 Intrexon Business Overview
11.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Introduction
11.7.4 Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.7.5 Intrexon Recent Development
11.8 Mesoblast
11.8.1 Mesoblast Company Details
11.8.2 Mesoblast Business Overview
11.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Introduction
11.8.4 Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
11.9.1 Pluristem Therapeutics Company Details
11.9.2 Pluristem Therapeutics Business Overview
11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.9.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.9.5 Pluristem Therapeutics Recent Development
11.10 Tissue Genesis
11.10.1 Tissue Genesis Company Details
11.10.2 Tissue Genesis Business Overview
11.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Introduction
11.10.4 Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.10.5 Tissue Genesis Recent Development
11.11 BioRestorative Therapies
11.11.1 BioRestorative Therapies Company Details
11.11.2 BioRestorative Therapies Business Overview
11.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Introduction
11.11.4 BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.11.5 BioRestorative Therapies Recent Development
11.12 Celltex Therapeutics Corporation
11.12.1 Celltex Therapeutics Corporation Company Details
11.12.2 Celltex Therapeutics Corporation Business Overview
11.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
11.12.4 Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.12.5 Celltex Therapeutics Corporation Recent Development
11.13 iXCells Biotechnologies
11.13.1 iXCells Biotechnologies Company Details
11.13.2 iXCells Biotechnologies Business Overview
11.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Introduction
11.13.4 iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.13.5 iXCells Biotechnologies Recent Development
11.14 Pluristem Therapeutics
11.14.1 Pluristem Therapeutics Company Details
11.14.2 Pluristem Therapeutics Business Overview
11.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.14.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.14.5 Pluristem Therapeutics Recent Development
11.15 Cyagen
11.15.1 Cyagen Company Details
11.15.2 Cyagen Business Overview
11.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Introduction
11.15.4 Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.15.5 Cyagen Recent Development
11.16 Lonza
11.16.1 Lonza Company Details
11.16.2 Lonza Business Overview
11.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Introduction
11.16.4 Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
11.16.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Autologous Stem Cells
Table 3. Key Players of Allogeneic Stem Cells
Table 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions (2016-2021)
Table 8. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions (2022-2027)
Table 10. Adipose Tissue-derived Stem Cell Therapy Market Trends
Table 11. Adipose Tissue-derived Stem Cell Therapy Market Drivers
Table 12. Adipose Tissue-derived Stem Cell Therapy Market Challenges
Table 13. Adipose Tissue-derived Stem Cell Therapy Market Restraints
Table 14. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players (2016-2021)
Table 16. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2020)
Table 17. Ranking of Global Top Adipose Tissue-derived Stem Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adipose Tissue-derived Stem Cell Therapy Product Solution and Service
Table 21. Date of Enter into Adipose Tissue-derived Stem Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. AlloCure Company Details
Table 62. AlloCure Business Overview
Table 63. AlloCure Adipose Tissue-derived Stem Cell Therapy Product
Table 64. AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 65. AlloCure Recent Development
Table 66. Antria Company Details
Table 67. Antria Business Overview
Table 68. Antria Adipose Tissue-derived Stem Cell Therapy Product
Table 69. Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 70. Antria Recent Development
Table 71. Celgene Corporation Company Details
Table 72. Celgene Corporation Business Overview
Table 73. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product
Table 74. Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 75. Celgene Corporation Recent Development
Table 76. Cellleris Company Details
Table 77. Cellleris Business Overview
Table 78. Cellleris Adipose Tissue-derived Stem Cell Therapy Product
Table 79. Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 80. Cellleris Recent Development
Table 81. Corestem Company Details
Table 82. Corestem Business Overview
Table 83. Corestem Adipose Tissue-derived Stem Cell Therapy Product
Table 84. Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 85. Corestem Recent Development
Table 86. Cytori Therapeutics Company Details
Table 87. Cytori Therapeutics Business Overview
Table 88. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
Table 89. Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 90. Cytori Therapeutics Recent Development
Table 91. Intrexon Company Details
Table 92. Intrexon Business Overview
Table 93. Intrexon Adipose Tissue-derived Stem Cell Therapy Product
Table 94. Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 95. Intrexon Recent Development
Table 96. Mesoblast Company Details
Table 97. Mesoblast Business Overview
Table 98. Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 99. Mesoblast Recent Development
Table 100. Pluristem Therapeutics Company Details
Table 101. Pluristem Therapeutics Business Overview
Table 102. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
Table 103. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 104. Pluristem Therapeutics Recent Development
Table 105. Tissue Genesis Company Details
Table 106. Tissue Genesis Business Overview
Table 107. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product
Table 108. Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 109. Tissue Genesis Recent Development
Table 110. BioRestorative Therapies Company Details
Table 111. BioRestorative Therapies Business Overview
Table 112. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product
Table 113. BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 114. BioRestorative Therapies Recent Development
Table 115. Celltex Therapeutics Corporation Company Details
Table 116. Celltex Therapeutics Corporation Business Overview
Table 117. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product
Table 118. Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 119. Celltex Therapeutics Corporation Recent Development
Table 120. iXCells Biotechnologies Company Details
Table 121. iXCells Biotechnologies Business Overview
Table 122. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product
Table 123. iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 124. iXCells Biotechnologies Recent Development
Table 125. Pluristem Therapeutics Company Details
Table 126. Pluristem Therapeutics Business Overview
Table 127. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
Table 128. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 129. Pluristem Therapeutics Recent Development
Table 130. Cyagen Company Details
Table 131. Cyagen Business Overview
Table 132. Cyagen Adipose Tissue-derived Stem Cell Therapy Product
Table 133. Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 134. Cyagen Recent Development
Table 135. Lonza Company Details
Table 136. Lonza Business Overview
Table 137. Lonza Adipose Tissue-derived Stem Cell Therapy Product
Table 138. Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 139. Lonza Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Autologous Stem Cells Features
Figure 3. Allogeneic Stem Cells Features
Figure 4. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application: 2020 VS 2027
Figure 5. Therapeutic Application Case Studies
Figure 6. Research Application Case Studies
Figure 7. Adipose Tissue-derived Stem Cell Therapy Report Years Considered
Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Adipose Tissue-derived Stem Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions (2022-2027)
Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players in 2020
Figure 13. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue in 2020
Figure 15. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 16. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 17. North America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2016-2027)
Figure 19. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2016-2027)
Figure 20. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2016-2027)
Figure 21. United States Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2016-2027)
Figure 25. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2016-2027)
Figure 26. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2016-2027)
Figure 27. Germany Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2016-2027)
Figure 37. China Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2016-2027)
Figure 45. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2016-2027)
Figure 46. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2016-2027)
Figure 47. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2016-2027)
Figure 53. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AlloCure Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 57. Antria Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 58. Celgene Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 59. Cellleris Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 60. Corestem Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 61. Cytori Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 62. Intrexon Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 63. Mesoblast Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 64. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 65. Tissue Genesis Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 66. BioRestorative Therapies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 67. Celltex Therapeutics Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 68. iXCells Biotechnologies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 69. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 70. Cyagen Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 71. Lonza Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.